← Leaderboards
Matthew Bryan Frieman
University Of North Carolina Chapel Hill
$7,852,081
Attributed
$7,852,081
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,852,081 · 7
By mechanism
R01$4,530,631 · 2
P01$2,058,407 · 1
R21$853,593 · 2
K22$266,270 · 1
F32$143,180 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Ralph S Baric$89,182,261
- Kevin M Weeks$22,683,080
- Raymond J Pickles$6,417,208
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusAnimal ModelPathogenesisMouse ModelInfectionCellsLeadResponseImmune ResponseCessation Of LifePathway InteractionsProteinsRespiratory VirusLungImmuneCoronavirus InfectionsSars CoronavirusCytokineAffectIn VivoLung DiseasesPredispositionMiddle East Respiratory Syndrome CoronavirusReceptor
Grant awards (21)
Coronavirus Challenge Core$616,900
P01 · FY2025 · AI · contact PI
Role of Diabetes in MERS Coronavirus Pathogenesis$550,837
R01 · FY2023 · AI · contact PI
Coronavirus Challenge Core$1,441,507
P01 · FY2022 · AI · contact PI
Role of Diabetes in MERS Coronavirus Pathogenesis$552,435
R01 · FY2022 · AI · contact PI
Role of Diabetes in MERS Coronavirus Pathogenesis$556,863
R01 · FY2021 · AI · contact PI
Broad Spectrum Anti-viral Compounds Targeting the SKI Complex$193,125
R21 · FY2021 · AI · contact PI
Role of Diabetes in MERS Coronavirus Pathogenesis$609,387
R01 · FY2020 · AI · contact PI
Broad Spectrum Anti-viral Compounds Targeting the SKI Complex$231,750
R21 · FY2020 · AI · contact PI
Diabetic Comorbidity and MERS Coronavirus Pathogenesis$195,381
R21 · FY2017 · AI · contact PI
Diabetic Comorbidity and MERS Coronavirus Pathogenesis$233,337
R21 · FY2016 · AI · contact PI
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis$121,986
R01 · FY2016 · AI · contact PI
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis$375,000
R01 · FY2015 · AI · contact PI
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis$528,500
R01 · FY2014 · AI · contact PI
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis$485,623
R01 · FY2013 · AI · contact PI
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis$375,000
R01 · FY2012 · AI · contact PI
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis$375,000
R01 · FY2011 · AI · contact PI
Inhibition of the Innate Immune Response by the SARS Coronavirus$108,000
K22 · FY2010 · AI · contact PI
Inhibition of the Innate Immune Response by the SARS Coronavirus$158,270
K22 · FY2009 · AI · contact PI
SARS-CoV Mediated Modulation of Innate Immunity$50,428
F32 · FY2007 · AI · contact PI
SARS-CoV Mediated Modulation of Innate Immunity$48,796
F32 · FY2006 · AI · contact PI
SARS-CoV Mediated Modulation of Innate Immunity$43,956
F32 · FY2005 · AI